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Abstract  
Ion mobility mass spectrometry (IM-MS) is a fast and sample-efficient method for analysing the 
gas phase conformation of proteins and protein complexes. Subjecting proteins to increased 
collision energies prior to ion mobility separation can directly probe their unfolding behaviour. 
Recent work in the field has utilised this approach to evaluate the effect of small ligand binding 
upon protein stability, and to screen compounds for drug discovery. Its general applicability, 
however, for high-throughput screening will depend upon new analytical methods to make the 
approach scalable. Here we describe a fully automated program, called Benthesikyme, for 
summarising the ion mobility results from such experiments. The program automatically creates 
collision induced unfolding (CIU) fingerprints and summary plots that capture the increase in 
collision cross section and the increase in conformational flexibility of proteins during unfolding. 
We also describe a program, based on a genetic algorithm, for the deconvolution of arrival time 
distributions from the CIU data. This multicomponent analysis method was developed to require 
as little user input as possible. Aside from the IM-MS data, the only input required is an estimate 
of the number of conformational families to be fitted to the data. In cases where the appropriate 
number of conformational families is unclear, the automated procedure means it is 
straightforward to repeat the analysis for several values and optimize the quality of the fit. We 
have employed our new methodology to study the effects of peptide binding to  α1-antitrypsin, 
an abundant human plasma protein whose misfolding exemplifies a group of conformational 
diseases termed the serpinopathies. Our analysis shows that interaction with the peptide 
stabilises the protein and reduces its conformational flexibility. The previously unresolved 
patterns of unfolding detected by the deconvolution algorithm will allow us to set up a fully 
automated screen for new ligand molecules with similar properties. 
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Introduction 
Ion mobility and native conformation 
Ion mobility mass spectrometry (IM-MS) is increasingly used in the field of structural biology to 
address a number of challenging questions relating to the structure and dynamics of proteins 
and protein complexes [1, 2]. IM-MS offers several advantages compared to more established 
tools used in the field, namely the ability to study proteins of high flexibility [3-5] and 
polydispersity [6], the ability to monitor and separate distinct conformational families co-existing 
in solution [7, 8] and all this whilst having modest sample requirements. IM-MS separates ions, 
typically generated from nano-electrospray ionization (nESI), based on their mass, charge and 
collision cross section (CCS). A large number of studies have shown that under carefully 
controlled experimental conditions and at low collision energies, the structures from IM-MS are 
closely related to those in solution for globular proteins and protein complexes [9-11]. 
Gas phase unfolding of proteins 
By intentionally increasing the internal energy of an ion prior to IM-MS analysis, however, a 
number of interesting observations can be carried out. In some of the early applications of IM-
MS to study protein structure, the groups of Jarrold, Clemmer and Bowers used injection energy 
studies to probe the unfolding of a number of model and disease-related proteins [12-14]. These 
experiments revealed the relative stability of different proteins. Proteins held together with 
disulphide bonds were more resistant to unfolding compared to those without them. Injection 
energy studies have also been used to probe the oligomeric state for a number of proteins 
involved in protein aggregation diseases. Oligomers dissociate to lower aggregation states and 
eventually to monomer at increasing injection energies [15]. 
Unfolding of protein complexes 
Collision induced dissociation (CID) followed by IM-MS analysis has also been used to study 
large protein complexes [10]. Unlike CID of peptides, which results in the fragmentation of the 
peptide bond, for non-covalent complexes the increase in energy results in unfolding, typically 
of the smallest surface accessible subunit and so the term collision induced unfolding (CIU) is 
used in this case. This unfolding is followed by an asymmetric dissociation of the complex with 
many charges from the precursor being transferred to the smallest subunit, which is now able 
to accommodate more charges due to its largest surface area, prior to its dissociation from the 
complex [16]. More recent work, however, has shown that the above process depends on the 
tertiary structure of the protein complex [17] and on the charge state selected for CIU [18]. 
Since its initial description, CIU has been used to study a number of different processes, 
including gas phase protein stability due to anion and cation binding [19, 20], peptide binding 
[21], and lipid binding selectivity [22]. 
Protein ligand binding and drug screening 
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Another major application area of the CIU-IM-MS approach is examining the effect of ligand 
binding on the protein or protein complex structure. Comparison of the arrival time distributions 
obtained at increased collision energies between apo- and ligand-bound forms, for a number 
of proteins [23] and protein complexes, enabled characterisation of the changes in structural 
stability induced by ligand binding. The influence of different ligand-bound states has also been 
examined, illustrating the power of this approach in studying heterogeneous systems having 
multiple ligand binding stoichiometries [24] [25]. 
Ligand-specific CIU signatures may report other consequences of ligand binding. This has been 
demonstrated for small molecule inhibitors of the protein kinase domain of the Abl protein. 
These are defined by their binding specificity as type I (non-specific for the active conformer of 
the Abl kinase domain) or type II (active state specific) inhibitors. Although binding of either type 
of ligand to the protein did not substantially alter the conformation at low collision energies, they 
displayed distinct unfolding signatures. These ‘reference’ type I and type II signatures were 
then compared to the CIU signatures of novel ligands to predict their inhibitory mechanism. 
[26].  
The need for computational tools 
Consequently, the unfolding of proteins and protein complexes in the gas phase followed by 
IM-MS analysis provides valuable information that cannot be easily obtained by other structural 
methods. The development of commercial IM-MS instrumentation [27] has also led to an 
expansion in the number of laboratories that have access to this technology. As a consequence 
of an increased IM-MS user base, and the development of new types of data acquisition 
methods such as CIU, new computational methods to process these data are required. 
Programs to process the IM-MS data [28, 29], and CIU data [30, 31] have been recently 
developed. It is particularly desirable to report data from IM-MS studies in a standardised, 
quantitative manner to allow them to be compared.  This requires the definition of parameters 
that reduce the dimensionality of IM-MS data whilst retaining important information about the 
ensemble behaviours that IM-MS is particularly well suited to characterise. 
Here we describe a new computational approach for the analysis of CIU experiments. We 
present the benefit of summarising the data using the intensity weighted mean (IWMATD) and 
standard deviation (IWSDATD) of each arrival time distribution (ATD). The results are a 
quantitative method for representing the degree of unfolding in terms of change in CCS. We 
also describe a new genetic-based algorithm for the deconvolution and subsequent 
multicomponent analysis of CIU, capable of dealing with the conformational heterogeneity of 
unfolding proteins. Deconvolution allows accurate determination of the centre of conformational 
populations. It also facilitates more accurate calculation of the abundance of each resolvable 
conformational family in comparison to existing methodology, which uses peak heights. To 
demonstrate the efficacy of these methods, three proteins that have been previously well-
characterised by native MS methods have been analysed; myoglobin, lysozyme and β-
lactoglobulin, as well as the protein α1-antitrypsin in both its apo-form and bound to a peptide 
previously shown to inhibit its aggregation. 
Benthesikyme, our software for summarizing the data is available from our website 
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(http://www.homepages.ucl.ac.uk/~ucbtkth/resources.html) while the genetic algorithm 
program is available on request.  
 
Materials and Methods 
Mass spectrometry sample preparation 
Proteins were analysed in 200 mM ammonium acetate (Sigma Aldrich, St. Louis, MO). Buffer 
exchange was carried out using BioRad (Hercules, CA) BioSpin 6 columns, with additional 
concentration and dilution steps using Amicon Ultra 0.5 ml centrifugal filter devices (Millipore 
UK Ltd, Watford, UK). The concentration of these samples was monitored using a Qubit 2.0 
fluorometer (Life Technologies, Carlsbaαd, CA). Samples were analysed after diluting to a final 
concentration of 10 µM. 
Peptide binding to α1-antitrypsin 
α1-antitrypsin was buffer exchanged into 250 mM ammonium acetate (pH 7) by 3 rounds of 
dilution-concentration using 10 kDa Millipore Amicron Ultra centrifuge filters. The Ac-TTAI-NH2 
peptide was also made up in ammonium acetate (pH 7). A molar ratio of 2:1 peptide:protein 
was used and the sample incubated for 72 hours at 37.5 degrees C before analysis. The final 
concentration of α1-antitrypsin was 15 μM. 
IM-MS analyses 
Experiments were performed on a Synapt HDMS mass spectrometer (Waters Corp., 
Manchester, UK) [27]. The Synapt geometry has two collision cells bracketing the ion mobility 
device. the trap, which Is situated before the IM device, and the transfer which is located after 
the IM device. To carry out CIU experiments, it is the voltage in the trap cell that is increased. 
The instrument was mass calibrated using 30 µM caesium iodide (Sigma Aldrich, St. Louis, 
MO) dissolved in 250 µM ammonium acetate. 2.5 - 4.5 µl aliquots of sample were delivered to 
the mass spectrometer using gold coated borosilicate capillaries prepared in-house [32]. 
The source temperature was 40 °C, the capillary voltage was set to 1.1 kV, and the cone voltage 
was kept at 30 V throughout all the experiments. The gas in the T-Wave IM separation cell was 
nitrogen, and the pressure was 0.54 mbar. The bias voltage was kept at 20 V while the T-Wave 
velocity was set to 350 m/s. The T-Wave height was optimised at 9 and 10 V for the study of 
the model proteins and α1-antitrypsin respectively. Unfolding of proteins was performed by 
varying the trap voltage. The TOF analyzer was operated in V-optic mode and tuned for an 
operating resolution of 9,000 FWHM. Mass spectra were acquired at an acquisition rate of 2 
spectra/sec with an interscan delay of 100 ms. 
CCS calibration curves were calculated using proteins with known collision cross sections [33] 
acquired using the same ion mobility parameters as the sample under study. The data were 
extracted and calibrations applied using the Amphitrite software package [29, 34]. 
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For the α1-antitrypsin unfolding experiments the quadrupole was used to isolate the +13 charge 
state. The CCS calibration curves for these experiments were determined using β-lactoglobulin 
monomer and dimer charge states as well as concanavalin A tetramer. 
Experiments analysing model proteins also used the quadrupole to isolate certain charge states 
(+7 lysozyme, +8 myoglobin and +8 β-lactoglobulin). All data reported for myoglobin are only 
for the heme-bound form. CCS calibration curves were calculated using BSA and bradykinin 
as the calibrants. 
Software development 
The genetic algorithm was developed in the C programming language before transferring to 
Cuda C. The software has been tested on GNU/Linux and Windows. Successfully tested 
graphics cards include Nvidia Tesla C1060, GeForce 560 Ti and 660 Ti. 
Processing and displaying the results generated by the genetic algorithm is handled by the 
Python programming language, in conjunction with Python modules Numpy, Scipy, Matplotlib 
and Amphitrite [29]. 
Simulated data are generated as a sum of Gaussian peaks as defined in Equation 1, where d 
is the number of data points per ATD, n the number of Gaussian distributions (conformations) 
being fit, S is the vector of simulated data points and μ, Γ and A are the mean position, full width 
half maximum (FWHM) and amplitude of the Gaussian distribution, respectively. 
 
Equation 1 
! = 	$$%&'( )*+,-	(	.+/01)2+ 1√1 45 1⁄ /07&89:;89  
 
 
Results 
Summarising unfolding data 
The large amount of data produced by collision induced unfolding experiments can be difficult 
to represent graphically. In many cases the ATDs are displayed by vertically stacking them. 
Such a figure illustrates the key structural features of each distribution clearly. When the number 
of energy conditions increases however, quantitative evaluation of multiple overlapping and 
emerging features can become difficult to discriminate between ATDs (for example see 
Supplementary Figure 1). Representing the relevant data directly as a user-friendly readout 
is important to allow the use of this strategy in a high-throughput setting [35] for rapid 
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identification of promising ‘hits’ without detailed, time-consuming, processing of the resulting 
raw data. 
To illustrate the issues involved in summarising ATD data, Figure 1A shows three hypothetical 
ATDs generated using Equation 1. Even though the maximum intensity is found at an arrival 
time of 10 ms in all three ATDs, the distributions are quite different. Simply selecting the position 
of the peak maximum, would not differentiate between them. ATD (a) consists of a single narrow 
conformational family, (b) has an additional conformation at a higher arrival time (shown as a 
shoulder on the main peak), while (c) represents an ATD that is much broader than that shown 
in (a).  
In order for a single metric to compactly summarise an ATD its calculation must capture 
changes in the average arrival time, in peak width, and the presence of distinct minor 
conformations. The intensity weighted mean of arrival times (IWMATD) is sensitive to changes 
in these features. IWMATD is calculated as in Equation 2, where I is the intensity in each time 
interval, t is the arrival time and n is the number of data points in the arrival time axis). 
 
Equation 2. 
 
<=>?@A = 	∑ <&7&89 C&∑ <&7&89  
 
The intensity weighted standard deviation (IWSDATD), calculated using Equation 3, is a 
complementary metric that reports the degree of conformational variation represented by the 
overall ATD and is directly comparable between different ATDs. 
 
Equation 3 
 
<=!D?@A = E∑ <&7&89 (C& − <=>?@A)1∑ <&7&89  
 
The IWMATD and IWSDATD values for the synthetic example are indicated on Figure 1A, and, 
as intended, these metrics summarise the properties of the distributions in a way that allows 
them to be distinguished, i.e. distributions (a) and (b) differ in both metrics, and while (a) and 
(c) have the same value for IWMATD, the IWSDATD value for (c) is much greater.  
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IM-MS CIU data were obtained on three model proteins, lysozyme, β-lactoglobulin and 
myoglobin (Figure 1B) and used to analyse the utility of this approach with real data. In order 
to remove the effects of mass and charge, and provide a direct comparison between proteins, 
we choose to convert the ATDs to CCSs (see materials and methods) and the trap collision 
voltages to laboratory frame voltage (charge state multiplied by voltage, which enables the 
comparison of different charge states). The equivalent metrics are then the intensity weighted 
mean of the CCS values (Equation 4) and the corresponding intensity weighted standard 
deviation (Equation 5). 
Equation 4 
<=>IIJ = 	∑ <&7&89 KK!&∑ <&7&89  
and 
Equation 5 
 
<=!DIIJ = E∑ <&7&89 (KK!& − <=>IIJ)1∑ <&7&89  
 
 
where I is the intensity in each CCS interval. 
Figure 1C shows the results of calculating the IWMCCS from the experimental data. For 
lysozyme, IWMCCS does not change as much as for the other two proteins. This is expected as 
lysozyme is held together with four disulphide bonds. Whilst β-lactoglobulin and myoglobin 
have very close CCSs at low energies, at higher energies myoglobin (that contains no 
disulphide bonds) unfolds more readily than β-lactoglobulin (stabilized by disulphide bonding).  
After the IWMCCS of myoglobin reaches its highest value, it starts to reduce. This effect is likely 
due to the heme group dissociating from the most extended conformational family, which 
causes a m/z shift outside the quadrupole isolation window, and consequently an over 
representation of the more compact conformations is observed. In Figure 1D the difference in 
CCS in relation to the CCS measured at the lowest voltage is shown. This representation 
simplifies for the direct comparison of proteins that differ in size. 
Figure 1E shows the intensity weighted standard deviation CCS (IWSDCCS) as a function of 
increasing collision energies. Regions with higher standard deviation values are indicative of 
conformational variability; the protein likely exists in several distinct conformations increasing 
the spread of the ATD. For myoglobin the highest IWSDCCS is observed at 100–200 V, (from 
the CCS data in Figure 1B this appears to correspond to a mixed population of semi-compact 
and more extensively unfolded protein) while for β-lactoglobulin this is observed at 180-280 V. 
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For both these proteins, there is a decline in this value at higher collision energies indicating 
that fewer distinct conformations are present. In contrast, for lysozyme the variability of the CCS 
increases almost uniformly, indicating that the protein is still experiencing relatively early, partial 
unfolding and has not begun converging on a single ensemble of structures. 
Summarising the data as described here allows for a reproducible and objective means of 
describing ATDs with no requirement for peak fitting to the data. These metrics are fast to 
perform, allow for the quantification of differences in stability and conformational diversity 
between different proteins and different bound forms of a protein.  The use of our described 
methodology therefore concisely reports upon multiple useful data characteristics present in 
the original ATDs or CCS vs. collision energy plots. 
 
Multicomponent analysis of ATDs 
The unfolding of proteins often yields several intermediate conformational families. Changes in 
the abundance of such intermediate conformational families can be used to compare different 
variants of a given protein, e.g. wild-type versus mutant forms, or to probe the effects of ligand 
binding to a protein. Up until now, estimates of the abundance of conformers have been made 
using peak heights at manually chosen drift times. The individual ATDs for each conformational 
family, however, are almost always never baseline resolved, therefore, inferring their 
abundance using peak heights does not provide a true reflection of their actual abundance. The 
strongly overlapped character of the data also makes the use of gradient descent optimisation 
techniques, such as non-linear least squares, inefficient in fitting individual Gaussians (used to 
represent one conformational family) to the data. Here we describe and evaluate a novel 
genetic algorithm (GA)-based approach for the fitting and deconvolution of ATDs obtained from 
gas phase unfolding experiments. 
Genetic algorithms (GAs) are a class of artificial intelligence optimisation algorithms, which 
mimic evolution in order to find an optimal solution. Potential solutions to a problem are encoded 
as chromosomes and a set of chromosomes make up a population. A single chromosome 
contains all the parameters which are to be optimised, which are known as genes. Populations 
of chromosomes evolve over a number of generations with different evolutionary processes 
operating on these genes and chromosomes (crossover, mutation) with each chromosome 
evaluated for its fitness in finding an improved solution [36, 37]. 
A purpose-built framework for deconvoluting unfolding data has been developed and is 
presented here. An important feature of proteins revealed in the ion mobility data is that, as a 
protein unfolds in the gas-phase, it shifts between discrete families of conformations and does 
not progressively unfold in a continuous manner. This feature is used as a constraint in the 
fitting procedure; multiple ATDs recorded at different collision energies are deconvoluted 
simultaneously but the peak centres of each conformation are kept constant across all ATDs.  
The fitness (F) of a chromosome is calculated as the additive inverse of the error. Two methods 
for calculating error can be used, the sum of absolute differences and the sum of squares. We 
choose to use the sum of squares error in Equation 6 where a is the number of ATDs in the 
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dataset, μ, Γ and A are the mean, full width half maximum (FWHM) and amplitude of each 
Gaussian distribution, respectively.  
 
 
Equation 6 
 
L = 	−	$$⎝⎛$O%&,P'
( )*+,-,Q(.+/01)2+,Q 1√1 45 1⁄ /0R17&89 − S;,P1 ⎠⎞
:
;89
V
P89  
 
 
 
This fitness measure adds a greater penalty for large deviations, in comparison to the sum of 
absolute differences, between experimental and simulated data allowing it to more aggressively 
optimise against larger deviations between the fit and the data. The result of this is that the 
algorithm obtains fits that are close to the original data within fewer generations.  
Multiple runs of the algorithm were performed in order to establish the optimal, mutation, 
crossover and population size (see Supplementary text and Supplementary Figures 3 and 4). 
 
Deconvolution and abundance analysis of CIU in model proteins  
To test our algorithm we first used it to deconvolute synthetically generated collision-induced 
unfolding data. The deconvolution algorithm achieved very good agreement with the original 
data (Supplementary Figure 2). We then tested our algorithm on the CIU data obtained for 
three model proteins β-lactoglobulin (~ 18 kDa), myoglobin (~ 17 kDa) and lysozyme (~ 14kDa). 
The results of the fitting process for β-lactoglobulin are shown in Figure 2. Agreement between 
experimental and simulated data, generated from parameters determined by the GA-based 
deconvolution, is very good with an overall error of 19.4 (the sum of all differences between 
simulated and original data as a proportion of the base peak). Individual conformations are 
coloured differently with the sum of all conformations coloured in red. There is a major structural 
transition between 120 and 280 eV. At voltages of 280 eV new conformational families, distinct 
from to those at voltages less than 120 eV, become populated. This observation is in agreement 
with the summary representation of such data shown in Figure 1, but here the individual 
conformational families can be deconvoluted and their areas quantified as shown in Figure 2B. 
The area under the curve for each conformation defined by deconvolution was normalised to 
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the percentage of all conformations present. Figure 2C shows the equivalent population 
estimates of each conformation when only peak heights are taken into account. Even though 
the overall trends shown in Figures 2B and 2C are similar, the relative abundances of each 
conformation are different. For the lowest collision energy, the adundances of the two major 
conformations, coloured blue and grey, are 63% and 35% using the peak height method, but 
79% and 20% for the peak area analysis thus illustrating the benefits of defining conformational 
abundance as the relative areas enclosed within deconvoluted peaks rather than simply using 
their heights.  
CIU-IM-MS characterization of α1-antitrypsin interaction with the tetrapeptide TTAI 
To illustrate the applicability of our new software in analyzing a real-world biological problem, 
we used it to study the effects of peptide binding on the conformational behavior of the protein 
α1-antitrypsin.  
α1-antitrypsin is the most abundant human plasma protease inhibitor, circulating at 
concentrations of 1–2 mg/ml.  Under physiological conditions α1-antitrypsin, like other members 
of the serpin (serine protease inhibitor) protein superfamily, adopts a metastable conformation 
upon folding within the cell. An unstructured region in the protein termed the reactive centre 
loop (RCL) is used as substrate for the target enzyme. A transition from a metastable to a 
hyperstabilised enzyme-complexed state underlies their functional mechanism [38] during 
which, following cleavage by the enzyme, the RCL inserts as an extra strand in the main beta-
sheet of α1-antitrypsin. Homopolymerisation of α1-antitrypsin, due to pathological mutations that 
enable strand insertion without cleavage, results in a disease called α1-antitrypsin deficiency 
which is associated with severe lung (early-onset, panacinar emphysema) and liver (hepatic 
cirrhosis, hepatocellular carcinoma) disease [39, 40]. 
We have recently analysed the interaction of α1-antitrypsin with TTAI, a peptide identified from 
a combinatorial chemistry approach that has been shown to inhibit α1-antitrypsin polymerisation 
[41], using a combination of native and ion mobility mass spectrometry, X-ray crystallography 
and NMR spectroscopy [25]. We observed that TTAI binds with a 2:1 peptide:protein 
stoichiometry and that binding of two copies of TTAI increases the conformational stability of 
α1-antitrypsin. We demonstrated that IM-MS is an ideal method for high-throughput screening 
of compounds for the inhibition of diseases mediated by protein kinetic instability. However, 
although the time required to obtain the CIU IM-MS data was much less than either the X-ray 
or NMR experiments, data analysis was limited and labor-intensive due to the lack of programs 
to process CIU data at that time. We therefore focused on deconvoluting the ATDs between 
bound and unbound versions at only one collision voltage representative of the most 
conformational variability. Here we revisit the binding of TTAI to α1-antitrypsin by a) acquiring 
many more collision voltages during the unfolding process and b) processing the data using 
our newly developed software so that abundance of each conformational family is measured 
across the entire CIU experiment. The ability to deal with more finely grained collision voltages 
during a CIU experiment ensures that greater detail of the structural transitions, at specific 
energies, is observed for the native (apo) form. This enables the study of conformational 
intermediates and how these are affected by small molecule / peptide binding events. 
The CIU fingerprints for apo and double TTAI-bound α1-antitrypsin are shown in Figure 3A. It 
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can be seen that the variation in CCS is greater for the apo protein than for the peptide-bound 
protein indicating that the double-bound protein has less conformational flexibility than the 
unbound protein. 
Unfolding curves were generated from the data, whereby the increase in IWMCCS is plotted 
against increases in the collision energy (Figure 3B and C). The unfolding curves in panel A 
show that even though the CCS of the double-bound protein is larger than the apo form under 
native-like conditions, as the collision energy increases the apo form appears to unfold more 
readily. This is shown more clearly when monitoring the change in CCS as a function of 
increasing collision energy. The double-bound form consistently demonstrates a reduced 
degree of unfolding in terms of increase in CCS. 
To quantify and further confirm the change in conformational flexibility seen in the CIU 
fingerprint analysis, the IWSDCCS was plotted (Figure 3D). Critically the bound form has a 30-
40% smaller IWSDCCS, indicating lower conformational heterogeneity, across all collision 
energies. This confirms that the reduction in conformational lability (increase in kinetic stability) 
induced by TTAI binding previously described at higher energies by CIU-IM-MS holds true at 
the lowest energy (most native-like) conditions. Towards the highest collision energy, the 
variability of the apo form appears to start increasing; this may indicate another unfolding event 
taking place. In contrast, these energies are associated with reduced variability in the ternary-
complex state. This indicates that at the highest energies studied the protein:peptide complex 
converges on a specific, stable conformation. It is possible, however, that this convergence 
could represent the behaviour of the peptide-bound state before peptide release since TTAI 
dissociation would cause a concomitant shift out of the region of the m/z spectrum selected for 
IM-MS analysis. 
Deconvolution of α1-antitrypsin data 
The summary statistics shown in Figure 3 confirm that on average the binding of TTAI stabilises 
the ensemble behaviour of α1-antitrypsin. We used our GA-based algorithm to understand this 
in more detail, in terms of the populations of different conformeric states within the ensemble. 
The results of the deconvolution are shown in Figure 4.  
In the original ATD data, families of different conformational states are indicated by inflection 
points (directly observable ‘peaks’, ‘shoulders’ and ‘tails’). The relative populations of the 
different states, however, cannot be directly assessed and then compared without 
deconvolution. α1-antitrypsin is a highly metastable protein in solution and so the composite 
ATD profile likely reflects varying rates of conformational exchange between different species 
in the gas phase during the timescale of the IM-MS experiment. Conformational exchange rates 
that are slow relative to this timescale will tend to cause distinct inflection points, whilst those 
that are more rapid will tend to cause peak broadening. Moreover, the differences in CCS 
between different conformer families of the same monomeric protein approach the technical 
limits of current resolution on the instruments used. Together these factors result in increased 
peak overlap. Deconvolution is therefore key to quantitative analysis of such phenomena. The 
results of such deconvolution using our GA-based algorithm are shown in Figure 4. 
Any deconvolution approach is potentially vulnerable to overfitting, whereby increasing the 
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number of species (i.e. the number of Gaussians to include in the deconvolution) will improve 
the apparent fit of the solutions to the data, beyond the resolution of the data. We were therefore 
keen to establish a quantitative method to select the appropriate number of families that the 
data could define. To this end we ran our GA algorithm several times, each time varying the 
number of conformational families (each represented by a Gaussian) to be fitted and the seed 
number used by the GA to randomly generate the initial population. The resulting ‘elbow plot’ 
of fitting error versus number of conformational families is shown in Supplementary Figure 5.  
This plot shows that the fitting error reaches a plateau beyond approximately 5 or 6 families. 
The results shown in Figure 4 from the fitting of the ATDs with 6 conformational families and 
from the run that resulted in the lowest fitting error.  
The individual peaks fitted to the data for the apo and holo forms of the protein are shown in 
Figures 4A and 4B respectively. The abundance for each deconvoluted peak is shown in 
Figures 4C and 4E while Figures 4D and 4F show the variation in FHWM for each peak across 
the collision energy ramp. 
The more compact conformational family, coloured in grey, is present over the same range of 
collision energies and persists until about 30 V, after which it disappears. However, the width 
of this family, as shown in figures 4D and 4F, is much narrower for the holo than the apo form, 
illustrating stabilization induced by peptide binding. This is consistent with a reduction in 
conformational lability relating to increased activation energy for transitions between states 
within the conformational family, that are more evident in the apo form. It is interesting to note 
that the third and fourth conformational families, coloured in purple and green, appear at much 
lower energies in the apo versus the holo form and persist over a larger range of voltages. We 
attribute the delay in appearance of these families in the holo-form to peptide-induced 
stabilization. 
Our program also allows the same data to be represented more intuitively, in heat map format 
so that both the conformation and the width of each family can be seen at once as seen in 
Figure 5. This view makes it much easier to evaluate the effects of peptide binding on the 
different conformational families. Such differences may have been difficult to detect and, 
certainly, to accurately quantify without multi-component deconvolution analysis of these data. 
Conclusions 
The benefits of statistically summarising gas phase unfolding data have been outlined here. By 
using the intensity-weighted mean (IWMATD and IWMCCS) and standard deviation (IWSDATD and 
IWSDCCS) to describe the ion mobility data (Figure 1) the degree of unfolding and 
conformational flexibility can be readily compared between different proteins and protein-ligand 
complexes. A novel method for deconvoluting IM-MS arrival time distributions, based on a 
genetic algorithm, is also presented. This approach offers a more accurate representation of 
the peak positions, abundance and CCS variation for each conformational family present in the 
unfolding data.  
The novel methodology described here provides many of the features necessary for application 
in high throughput drug discovery. Data can be automatically acquired by chip-based nESI 
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robots like the TriVersa NanoMate. Raw data can be extracted in an automated fashion using 
our previously published software, Amphitrite [29]. Our current software can then automatically 
create unfolding and variability curves along with CIU fingerprints. The software presented here 
reports quantitative measures of benefit when screening putative drug molecules for their 
effects upon the conformational behaviour of the protein.  For proteins liable to pathogenic 
conformational change each of these measures may have specific relevance. In the case of a1-
antitrypsin, the conformational variability of disease variants may correlate better with 
pathogenicity than overall stability or resistance to unfolding [25, 42].  
In a high throughput process, our summary metrics could allow standardised selection of 
molecules of interest for subsequent, in-depth analysis, by the GA deconvolution algorithm. An 
example of this would be to select ligands where at a given voltage the percentage change in 
CCS is under 5 % and the standard deviation is under 150 Å2. Without the introduction of robust 
CIU processing software the use of consistent threshold values would not be possible due to 
the high variability of manual interpretation. 
The GA deconvolution algorithm can produce detailed information for the unfolding process 
within the same time frame as the data acquisition. For increased accuracy we would 
recommend proceeding to run the GA multiple times with varying number of conformational 
families as this will provide evidence that helps in selecting the most appropriate number of 
Gaussian peaks to fit to the data. Running the GA a few times with different random seeds, 
used by the GA to generate the initial population, can have an effect on the resulting fit. The 
user can then assure themselves of the robustness of the fitting procedure and select the run 
resulting in the lowest overall error.  
We have illustrated how this approach can be used for this purpose by studying the effects of 
peptide binding on the medically important protein α1-antitrypsin. Our current analysis reveals 
a more in-depth picture of how peptide binding alters intermediate stability compared to our 
previous study [25]. Future work will involve screening a large number of drug molecules 
against wild-type and disease variant forms of α1-antitrypsin. Once a large number of molecules 
are screened, machine learning methods can be used to classify them and generate 
‘fingerprints’ such as in the work of [26]. The availability of such fingerprints would likely further 
limit the time of experimental analysis as only data at select collision energies would be required 
in order to classify the behavior of a new drug. 
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Figures 
 
 
 
Figure 1. (A) Synthetic data demonstrating spectral differences that can be identified by the proposed 
summary statistics  - Arrival time (td) of the spectral maximum is shown as blue line and the intensity 
weighted average (IWMATD) is marked in red and the intensity weighted standard deviation (IWSDATD) 
given in the top right of each panel; (B) CIU fingerprints for lysozyme (left), β-lactoglobulin (middle) 
and myoglobin (right); Unfolding curves for model proteins presented as (C) intensity weighted mean 
collision cross-section (IWMCCS), (D) change in IWMCCS, and (E) IWSDCCS (indicative of 
conformational variability). 
 
 
 
Figure 2 
Deconvolution and abundance analysis of β-lactoglobulin gas phase unfolding. (A) Deconvoluted 
ATDs, experimental data is shown in black and the simulation is red, individual conformations are 
coloured the same throughout the figure. (B) Relative proportions of deconvoluted conformational 
families assessed by area under the corresponding Gaussian. (C) Relative abundance determined 
using peak height analysis. 
 
Figure 3 
α1-antitrypsin collision induced unfolding fingerprints (A) for apo (left) and TTAI-bound (right); (B) 
unfolding curves showing the IWMCCS at varying collision energies, (C) as with (B) except showing 
change in IWMCCS from the lowest voltage, (D) Conformational variability analysis; IWSDCCS vs. 
collision energy. 
  
Figure 4 
Deconvolution of gas phase unfolding data for apo (A) and double bound (B) α1-antitrypsin. 
Experimental data is shown in black, with the sum of the deconvolution in red. The deconvoluted 
distribution of each conformation is shown with coloured lines. The abundance analysis of each 
conformational family determined by the deconvolution is shown for the apo (C) and holo (E) protein 
with the FWHM for each of the deconvoluted peaks shown in E and F respectively. 
 
 
Figure 5 
 
Deconvoluted CIU fingerprints. Each conformational family is shown as a heat map during the 
collision energy ramp. Both the intensity and width of each conformation can be seen at the same 
time. To make each conformational family clearer, the arrival time axis is shown as the difference 
from the conformation mean, shown for each plot in the bottom left. 
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Supplementary Text 
 
Genetic Algorithm optimisation 
 
Genetic algorithms are inspired by Darwin’s theory of evolution. Problems are solved by an 
evolutionary process resulting in the best (fittest) solution. Potential solutions to a problem 
are encoded as chromosomes with a set of chromosomes making up a population. A single 
chromosome contains the individual parameters to be optimized, referred to as genes. 
Evolutionary processes acting on the population include crossover and mutation. 
 
The basic outline of a genetic algorithm is:  
1. Creation of a random population of k chromosomes  
2. Evaluation of the fitness f(x) for each chromosome x (see equation 6 in main text) 
3. Creation of a new population  
(a) Two parent chromosomes are selected from the population (Selection) 
  (b) A crossover operation is performed between the parents to create offspring  
chromosomes (Crossover)  
(c) The resulting offspring chromosomes are mutated (Mutation)  
(d) The newly derived chromosomes are placed back in the population  
4. The new population is used to evaluate the fitness of each new chromosome  
5. A check is performed to evaluate whether an end condition is satisfied  
 
 
Crossover 
 
Crossover is the method used to simulate the biological process of recombination. The 
genes (parameter values) of two parent chromosomes are mixed together to create the 
offspring. There are several different crossover implementations, and two common methods 
are compared here. In single point crossover, a point along the chromosome is randomly 
chosen, the genes after that point are taken from one parent chromosome and the genes 
before from the other. The second method is uniform crossover where each gene of the 
offspring is independently randomly chosen from one of the parents. The single point 
crossover is most true to the biological process of recombination and only requires a single 
random number to be generated. In comparison, for uniform crossover many random 
numbers have to be created at each generation, which can cause a significant increase to 
computation time. Uniform and single-point crossover search parameter space differently 
and one may converge to a good solution more quickly than the other for particular 
problems. 
 
To test the two crossover methods, the lysozyme data set was run with a population size of 
2,000, using three different mutation rates. The algorithm was run 32 times using different 
random number generator seeds to ensure that the different runs followed different 
evolutionary paths and the results are shown in Supplementary Figure 3A. 
Single point crossover outperformed uniform crossover at the highest mutation rate, 
however this was not maintained for lower mutation rates where uniform crossover resulted 
in better convergence. The single point crossover took only 81 % of the time taken by the 
uniform method when all other factors were constant, however the single point method 
resulted in 33 % greater variation between runs at lower mutation rates.  
 
Mutation rate 
	 2	
 
The probability that a gene (parameter value) will be mutated in each generation. High 
mutation rates mean that a larger variety of values can be tested, which is especially 
important with small population sizes. Detrimentally, high mutation rates can disrupt the 
convergence of the genetic algorithm by introducing too much randomness for the other 
simulated evolutionary processes to function. 
 
Three mutation rates, 0.01 (representative of a 1 % mutation chance), 0.001 and 0.0001, 
were compared and the results are shown in Supplementary Figure 3A. The highest 
mutation rate performed very poorly, with much higher error values than the lower mutation 
rates.  
 
The difference between mutation rates 0.001 and 0.0001 is small, and although the average 
error is lower using the lowest mutation rate, the standard deviation is higher. To further 
investigate this, a histogram was plotted (Supplementary Figure 3B), and here we can see 
that though the variability is greater for the lowest mutation rate the distribution of the error 
values is better in comparison to the 0.001 mutation rate. 
 
There is additionally a small time benefit for using lower mutation rates, as new values have 
to be generated less frequently. Upon testing, the 0.0001 mutation rate took 5 % less time 
to complete than the 0.001 mutation rate. 
 
Population size 
 
An important factor in the performance of a genetic algorithm is the population size, or 
number of chromosomes per generation. Larger population sizes improve the chance that 
the solution to a problem can be constructed from the initial population without having to rely 
on mutation to generate appropriate genes. This comes at the cost of the run time of the 
program as the amount of computation required scales linearly with the number of 
chromosomes which are to be processed.  
 
In order to select an appropriate population size to use for experimental data the lysozyme 
dataset was tested again. Uniform crossover was used with a 0.0001 mutation rate for a 
variety of population sizes. The algorithm was run for 200,000 generations and each result 
was replicated six times using different random number seeds, the results are shown in 
Supplementary Figure 4. 
 
The smaller population sizes, 50, 500 and 1,000, all perform substantially worse than 2,000 
and 8,000. The difference between population sizes 2,000 and 8,000 is much smaller. The 
latter population does consistently perform better, but it may not be worth the additional 
computation time.  
 
 
The lowest average standard deviation in parameters achieved overall was using uniform 
crossover at a mutation rate of 0.0001. The additional time taken to run the uniform 
crossover method is not important given its better convergence. Users of our software can 
pick which population size, crossover implementation and mutation rate to use. Results 
presented all use a population of 2000, uniform crossover and a 0.0001 mutation rate. 
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Number of generations to achieve convergence 
 
The algorithm runs for a certain number of rounds of simulated evolution, with each round 
known as a generation. The error from one generation to the next never worsens, due to the 
use of elitism, where the best chromosome from the last generation is retained. 
 
The comparison of the effect of generations is shown in Suppl. Figure 4. Generation 0 
indicates the error for the fittest chromosome in the starting population, and the biggest 
reduction in error is shown in the first 50,000 generations. Supplementary Table 1 shows 
the reduction in error from each additional set of 50,000 generations, and it shows that 
though the initial decrease in error is the largest, there is still consistent improvement even 
to 200,000 generations. This indicates that the algorithm could still achieve a lower error, 
and when running the algorithm it is preferable to run it for as many generations as possible 
and examine convergence. 
On the GPU-equipped computer used for these calculations, it took approximately 1 hour to 
run using the optimum settings above for 200,000 generations. 
 
Generation Error DeltaError 
0 5587.1 n/a 
50000 106.4 -5480.7 
100000 95 -11.4 
150000 85.1 -9.9 
200000 77.8 -7.4 
 
Supplementary Table 1. Table showing the average error and the change in error over the 
previous 50,000 generations for the population size of 2,000. Data are taken from 
Supplementary Figure 4. 
 
Further as a rough cost-benefit analysis, the average error at 50,000 generations for 8,000 
population size can be compared to that at 200,000 generations for the 2,000 population 
size, as the computation time would be approximately equal. The average error for the 
smaller population was 77.8 against 100.8 for the population size of 8,000. This is an 
additional argument for the use of a population size of 2,000.  
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Supplementary figures 
 
Supplementary Figure 1. Gas phase unfolding of protein standards: arrival time 
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distributions for A) lysozyme (blue), B) β-lactoglobulin (green) and C) myoglobin (black).  
 
 
 
 
 
Supplementary Figure 2. Results of the deconvolution algorithm. (A) Synthetic collision 
energy ramp data. (B) The sum of the deconvolution is shown in red and the individual peaks 
shown in other colours. (C) The deconvolved peak height (plain line) and peak area analysis 
(line with dots) for the data. (D) the error, calculated using Equation 6 in the main text, of 1 
million randomly generated solutions is shown as a histogram and as a fitted Gaussian 
distribution in green. The error from the fittest solution generated by the genetic algorithm is 
shown as a vertical red line. The random solution error was tested for normality using the 
Anderson-Darling test, and by integrating above and below the algorithm error, it was 
determined that the probability of a random solution having the same error or less was 1.06 
× 10−23. 
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Supplementary Figure 3. Optimising the mutation rate and crossover parameters, for 
experimental data. The algorithm was run 32 times for each combination of settings using 
the lysozyme dataset and a population size of 2,000, and the results are shown in (A). The 
error bars indicate the spread of 2 standard deviations. (B) Histogram comparing the error 
results for the two best performing configurations, uniform crossover with mutation rates of 
0.001 and 0.0001. 
 
 
 
 
Supplementary Figure 4. Optimising the population size for experimental lysozyme data. 
The algorithm was run for 200,000 generations and the error for each population size (as 
coloured in legend) was checked every 50,000 generations. The error bars show the spread 
of two standard deviations, and the inset is a magnification of the main figure. 
 
 
	 7	
 
 
Supplementary Figure 5. Determining the optimal number of conformations (each 
represented by a Gaussian peak) to fit the data. For each number of Gaussians fitted, the 
genetic algorithm was run 25 times. The plot shows the decrease in the mean error between 
experimental and calculated data as the number of Gaussian increases with no major gains 
in performance obtained above 6 Gaussians. Error bars indicate the standard deviation 
between runs.  
 
 
